NCT05184231 Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China Status WITHDRAWN Phase N/A
NCT05149495 Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery Status UNKNOWN Phase N/A
NCT04860037 Micromegaly and Discrepancy Between Growth Hormone and IGF1 at the Diagnosis and Follow-up of Acromegalic Patients Status UNKNOWN Phase N/A
NCT04837040 A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04522180 A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly Status COMPLETED Phase PHASE2
NCT04520646 A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy Status UNKNOWN Phase NA
NCT04261712 A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04138537 Olfactory Function and Olfactory Bulb Volume in Acromegaly Patients Status COMPLETED Phase NA
NCT04125836 A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly Status COMPLETED Phase PHASE3
NCT04076462 A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly Status COMPLETED Phase PHASE3
NCT04003519 Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly Status WITHDRAWN Phase N/A
NCT03967249 Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands Status COMPLETED Phase PHASE2
NCT03849872 Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788 Status COMPLETED Phase PHASE1
NCT03792555 A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) Status COMPLETED Phase PHASE2